<div id="readability-page-1">Bristol-Myers Squibb (BMY) shares fell for seven straight sessions, as the stock was down 0.9% at $55.64 on Monday. The New Jersey-based pharma giant fell 3.5% in the preceding six sessions. The stock is down 5% over the past one month, while it has advanced 4% so far this year. Most recently, Bristol-Myers Squibb reported better-than-expected Q1 2...</div>

百时美施贵宝

医疗业 ETF - SPDR

纳斯达克生物科技指数 ETF - iShares Nasdaq

<p>百时美施贵宝（BMY）股票连续七个交易日下跌，周一下跌 0.9%，报 55.64 美元。该股在之前六个交易日中下跌了 3.5%，过去一个月下跌了 5%，尽管年初至今上涨了 4%。该公司最近公布的第一季度业绩好于预期</p>

Bristol-Myers Squibb shares fell for seventh consecutive session

医药 3 倍做多 - Direxion

医药突破 ETF - ALPS

2 倍做多纳斯达克生物技术 ETF - ProShares

美国制药 ETF - iShares

基因改革 ETF - ARK

动态生物技术与基因组 ETF - Invesco

生物科技 ETF - VanEck Vectors

标普全球医疗股指数 ETF - iShares

2 倍做空卫生保健 ETF - ProShares

医疗业 ETF - Vanguard

Invesco Nasdaq Biotechnology ETF

标普生物技术 ETF - SPDR

标普生物技术 3 倍做多 - Direxion

纽交所高增长板生物技术指数 ETF - First Trust

Bristol-Myers Squibb Company

百时美施贵宝的股价已经连续七个交易日下跌